Orthopedic Biomaterials

Medtronic Reveals Launch of Japan’s First Demineralized Bone Matrix Bone Grafting Device

No comments
Medtronic Reveals Launch of Japan’s First Demineralized Bone Matrix Bone Grafting Device

Register to receive a free U.S. Market Report Suite for Orthopedic Biomaterials report synopsis and brochure Medtronic announced the launch of the Grafton™ Demineralized Bone Matrix (DBM) for spine and orthopedic procedures on February 28th, 2019. Grafton™ DBM is the first ever demineralized bone matrix product available in Japan, which is the world’s second largest

iData ResearchMedtronic Reveals Launch of Japan’s First Demineralized Bone Matrix Bone Grafting Device
read more

Allosource Announces First Patient in ProChondrix Study

No comments
Allosource Announces First Patient in ProChondrix Study

 Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure Allosource has recently enrolled the first patient in a study entitled “A Prospective, Multi-Center Study Evaluating ProChondrix® CR for the Repair of Focal Articular Cartilage Defects in the Knee”. Allosource is a prominent industry figure in advancing transplantable allogenic cells and tissue.

iData ResearchAllosource Announces First Patient in ProChondrix Study
read more

3 Challenges To The Orthopedic Biomaterials Market In 2019

No comments
3 Challenges To The Orthopedic Biomaterials Market In 2019

Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure In recent years, several market pressures have caused a shift in market outlook for orthopedic biomaterial products. Although the market continues to grow year over year, average selling prices (ASPs) are declining as a result of these pressures. Our research shows that

iData Research3 Challenges To The Orthopedic Biomaterials Market In 2019
read more

SpinalCyte Announces New International Patent

No comments
SpinalCyte Announces New International Patent

Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure On January 8th, SpinalCyte LLC announced the issuance of a new Australian patent. The intellectual property portfolio for their leading product, CybroCell, now contains 36 international patents with 40 more pending. “This new Australian patent further expands our robust international intellectual property

iData ResearchSpinalCyte Announces New International Patent
read more

Kuros Receives FDA 510(k) Clearance for Extending Commercial Indications of MagnetOs Putty in the United States

No comments
Kuros Receives FDA 510(k) Clearance for Extending Commercial Indications of MagnetOs Putty in the United States

Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure Kuros Biosciences announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for extending MagnetOs Putty indications to use as a stand-alone bone graft in extremities and pelvis. This is in addition to the existing clearance for

iData ResearchKuros Receives FDA 510(k) Clearance for Extending Commercial Indications of MagnetOs Putty in the United States
read more

Synergy Biomedical Announces Launch of BIOSPHERE MIS PUTTY

No comments
Synergy Biomedical Announces Launch of BIOSPHERE MIS PUTTY

Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure Synergy Biomedical, LLC, a developer of innovative biomaterial products, announced that it has received FDA 510(k) clearance and is proceeding with a full commercial launch of BIOSPHERE® MIS PUTTY. BIOSPHERE® MIS PUTTY utilizes a pre-loaded bone graft cannula and trigger-based delivery system

iData ResearchSynergy Biomedical Announces Launch of BIOSPHERE MIS PUTTY
read more

Baxter Announces U.S. FDA Clearance of New Bone Graft Substitute, Actifuse Flow

No comments
Baxter Announces U.S. FDA Clearance of New Bone Graft Substitute, Actifuse Flow

Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure Baxter International Inc., a global leader in advancing surgical innovation, announced U.S. Food and Drug Administration (FDA) clearance of Actifuse Flow Bone Graft Substitute for use in a variety of orthopedic surgical procedures. As the newest addition to Baxter’s growing osteobiologics surgery

iData ResearchBaxter Announces U.S. FDA Clearance of New Bone Graft Substitute, Actifuse Flow
read more

NuVasive Launches AttraX Scaffold Bone Graft

No comments
NuVasive Launches AttraX Scaffold Bone Graft

Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure San Diego, California-based NuVasive, Inc. has announced the U.S. launch of AttraX Scaffold, the company’s absorbent ceramic-collagen bone graft with an optimized surface. According to the company, “Unlike traditional ceramic materials that do not by themselves generate bone formation when implanted in

iData ResearchNuVasive Launches AttraX Scaffold Bone Graft
read more

Newly Founded Company, Datum Orthobiologics, to Apply Dental Technology in Orthopedics

No comments
Newly Founded Company, Datum Orthobiologics, to Apply Dental Technology in Orthopedics

Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure Datum Biotech Ltd. has announced the founding of Datum Orthobiologics Ltd. Datum Orthobiologics will focus on creating advanced biomaterials for orthopedics based on proven bone formation and tissue regeneration solutions. These bio-programmable medical devices are designed to contribute to long-term healing

iData ResearchNewly Founded Company, Datum Orthobiologics, to Apply Dental Technology in Orthopedics
read more

Medtronic Announces FDA Approval of Infuse(TM) Bone Graft in New Spine Surgery Indications Using PEEK Interbody Implants

No comments
Medtronic Announces FDA Approval of Infuse(TM) Bone Graft in New Spine Surgery Indications Using PEEK Interbody Implants

Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure Medtronic plc announced U.S. Food and Drug Administration (FDA) approval of Infuse(TM) Bone Graft in new spine surgery indications. InfuseBone Graft is now approved for use with additional spine implants made of polyetheretherketone (PEEK) in oblique lateral interbody fusion (OLIF 25(TM)

iData ResearchMedtronic Announces FDA Approval of Infuse(TM) Bone Graft in New Spine Surgery Indications Using PEEK Interbody Implants
read more